Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Feasibility of Non-invasive Hemodynamic Assessment by 5D Flow in Congenital Heart Disease in Comparison to Right-left Heart Catheterization

NCT07742046 is registered in ClinicalTrials.gov with Tobias Rutz as lead sponsor.

NCT NCT07742046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07742046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Feasibility of Non-invasive Hemodynamic Assessment by 5D Flow in Congenital Heart Disease in Comparison to Right-left Heart Catheterization
Lead sponsor
Tobias Rutz
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
July 6, 2026
Completion date
May 31, 2029
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fontan circulation, pulmonary hypertension, right ventricular outflow tract dysfunction